2028 Clinical Research Disease Trials 
Drug Discovery World
DECEMBER 7, 2022
Data analytics company Phesi analysed 2,358 clinical trials involving collagen. In the first 10 months of 2022, there were more than 225 new trials, compared with 125 in 2012. billion by 2028. Phesi’s analysis shows that just 27% of trials received industry funding. billion USD, and is expected to grow to $16.7
Drug Discovery World
SEPTEMBER 28, 2022
Whilst we know that AI has been effective in practices such as validating targets that may be suitable to treat a disease, it faces a plethora of significant challenges. In fact, the market research firm, Bekryl, predicts that AI has the potential to offer over $70 billion in savings for the drug discovery process by 2028. .
Drug Discovery World
AUGUST 10, 2022
In 1987, researchers developed the chimeric antigen receptor (CAR) as an alternative means to identify cancer cells and direct T cells to attack them. And now, with more than 600 CAR T trials recruiting or ongoing, these cells represent a majority of the cellular immunotherapies in development today. Training T cells to target tumours.
Expert insights. Personalized for you.
130 
Let's personalize your content